13F-HR: Carlyle Group Discloses $13.5B Q4 2025 Equity Holdings

Carlyle Group Inc. filed its Q4 2025 13F-HR report, revealing $13.57 billion in equity holdings across 20 positions, including significant stakes in Medline Inc. and Standardaero Inc.

Summary

• Carlyle Group Inc. filed its Form 13F-HR report for the calendar quarter ended December 31, 2025, on February 13, 2026.
• The total market value of reported equity holdings is $13,566,904,392.
• The report lists 20 distinct equity positions.
• This is a 13F Combination Report, indicating that a portion of Carlyle Group's holdings are reported in this document, while others are reported by other managers.
• Three other institutional investment managers are included in this report: Abingworth LLP, Carlyle Investment Management LLC, and CIM Global, L.L.C.
• AlpInvest Partners B.V. is an indirectly wholly-owned investment adviser of The Carlyle Group Inc., though Carlyle Group Inc. does not participate in its investment decision-making.
• The Carlyle Group Inc. completed its acquisition of the Abingworth group in August 2022, making Abingworth LLP a relying advisor.
• The largest holdings by value include Medline Inc. with $9,042,727,512 and Standardaero Inc. with $4,378,687,194.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as 13F reports are primarily backward-looking disclosures of portfolio holdings and do not provide forward-looking guidance or performance metrics for the reporting manager.

Positives

• Disclosure of a substantial equity portfolio valued at over $13.5 billion, reflecting significant investment activity.
• Diversification across 20 different equity positions, indicating a broad range of investments.

Negatives

• This filing is a snapshot of past holdings and does not provide forward-looking performance or management commentary on portfolio strategy.

Risks

• The value of the reported holdings is subject to market fluctuations and general economic conditions.
• Concentration risk exists with Medline Inc. and Standardaero Inc., which together account for a significant portion of the total reported value, making the portfolio sensitive to the performance of these specific companies.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that 13F filings provide valuable transparency into the holdings of major institutional investors, offering insights into their investment strategies and market sentiment. Carlyle Group's significant holdings in companies like Medline Inc. and Standardaero Inc., which are often associated with private equity investments, reflect its core business model and strategic focus within the broader financial industry.

Comparison to Industry Standards

• Carlyle Group's reported equity holdings of $13.57 billion for Q4 2025 are substantial, aligning with the scale of major global institutional investment managers.
• The portfolio's concentration in Medline Inc. ($9.04 billion) and Standardaero Inc. ($4.38 billion) reflects a common strategy among private equity firms to hold significant stakes in portfolio companies, which may not be directly comparable to diversified public equity funds managed by traditional asset managers.

Stakeholder Impact

• Shareholders: Provides transparency into Carlyle Group's equity investment activities and portfolio composition, offering insight into the firm's investment strategy.
• Investment Professionals: Offers valuable data for analyzing the investment trends and specific holdings of a major institutional investor, aiding in market research and competitive analysis.

Key Dates

Keywords

Carlyle Group, 13F, Institutional Holdings, Equity Portfolio, Investment Management, Q4 2025, Medline, Standardaero, Abingworth, AlpInvest